2024+SFMV共识声明：静脉血栓栓塞性疾病未解决的问题—肥胖患者静脉血栓栓塞的管理.pdfVIP

JMV—JournaldeMédecineVasculaire49(2024)170—175

Availableonlineat

ScienceDirect

RECOMMENDATIONS

Unresolvedquestionsonvenous

thromboembolicdisease.Venous

thromboembolism(VTE)managementin

obesepatients.Consensusstatementofthe

FrenchSocietyofVascularMedicine(SFMV)

a,∗b

SébastienMiranda,MarjolaineTalbot,

cd,e

IsabelleGouin-Thibault,BenjaminEspinasse,

b

GuillaumeMahe,onbehalftheSFMV

aDepartmentofVascularMedicine,UniversityHospitalRouen,76000Rouen,France

bDepartmentofVascularMedicine,UniversityHospitalRennes,Rennes,France

cDepartmentofHemostasis,UniversityHospitalRennes,Rennes,France

dDepartmentofVascularMedicine,UniversityHospitalBrest,Brest,France

eUMR1304,Grouped’ÉtudedeThrombosedeBretagneOccidentale,CIC-Inserm1412,BrestUniversity,

Brest,France

Availableonline27August2024

KEYWORDSSummaryObesityisanalarmingworldwidepublichealthissueandisdefinedasabodymass

Obesity;index(BMI)of30kg/m2ormore.Itisconsideredasariskfactorforfirstthromboticeventandis

Venousassociatedwithasignificantriskofrecurrence.Consequently,obesepatientsareoftentreated

thromboembolismbyanticoagulanttherapybutdatafromrandomisedcontroltrialarescarce.Wewillreviewin

disease;thisnarrativereviewthestateoftheartoftheprescriptionofanticoagulantfortheprevention

Anticoagulantsandtreatmentofvenousthrombo